2020-09-01
Targeting CGRP in migraine: a matter of choice and dose
Publication
Publication
The Lancet Neurology , Volume 19 - Issue 9 p. 712- 713
Additional Metadata | |
---|---|
hdl.handle.net/1765/130483 | |
The Lancet Neurology | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Al-Hassany, L., & Maassen van den Brink, A. (2020). Targeting CGRP in migraine: a matter of choice and dose. The Lancet Neurology, 19(9), 712–713. Retrieved from http://hdl.handle.net/1765/130483 |